Navigation Links
SCOLR Pharma, Inc. Appoints Stephen J. Turner as CEO
Date:8/31/2009

patented CDT platform to develop novel pharmaceutical, over-the-counter (OTC), and nutritional products. Our CDT drug delivery platforms are based on multiple issued and pending patents and other intellectual property for the programmed release or enhanced performance of active pharmaceutical ingredients and nutritional products. For more information on SCOLR Pharma, please call 425.368.1050 or visit http://www.scolr.com/.

This press release contains forward-looking statements (statements which are not historical facts) within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve risks and uncertainties, including activities, events or developments that we expect, believe or anticipate will or may occur in the future. A number of factors could cause actual results to differ from those indicated in the forward-looking statements, including our ability to advance development of our potential products and complete research and development, our ability to raise additional funds or enter strategic alliances, the continuation of arrangements with our product development partners and customers, competition, government regulation and approvals, and general economic conditions.. Additional assumptions, risks and uncertainties are described in detail in our registration statements, reports and other filings with the Securities and Exchange Commission. Such filings are available on our website or at

SOURCE SCOLR Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. SCOLR Pharma, Inc. Submits Abbreviated New Drug Application for a 12-hour CDT-based Pseudoephedrine Formulation
2. SCOLR Pharma, Inc. Schedules Third Quarter 2008 Financial Results Conference Call for November 7, 2008 at 11:30 A.M. Eastern
3. SCOLR Pharma, Inc. Announces Positive Top-Line Results From Pivotal Clinical Trial Evaluating Efficacy of Extended-Release Ibuprofen
4. SCOLR Pharma, Inc. Announces Resignation of CEO Daniel O. Wilds
5. SCOLR Pharma, Inc. Announces Appointment of Bruce S. Morra, Ph.D., as President & CEO
6. SCOLR Pharma, Inc. Schedules Fourth Quarter 2008 Financial Results Conference Call for March 11, 2009 at 11:30 A.M. Eastern
7. SCOLR Pharma, Inc. Announces Engagement of HealthPro as Financial Advisor
8. SCOLR Pharma, Inc. Schedules First Quarter 2009 Financial Results Conference Call for May 1, 2009 at 11:30 A.M. Eastern
9. SCOLR Pharma, Inc. Reports First Quarter 2009 Financial Results
10. GeoPharma, Inc. to Present at the EdgeWater Research Investor Conference
11. TyRx Pharma, Inc. Announces Presentation of Results to Benefit Women with Breast Implants (In-Vivo Efficacy Study Regarding AIGISRx DEB) at the Plastic Surgery 2007 Meeting on October, 28 2007 in Baltimore, MD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... Colo. (April 17, 2014) Two recent papers ... researcher and colleagues may help scientists develop treatments ... Yellow fever, Japanese encephalitis and other disease-causing flaviviruses. ... biochemistry and molecular genetics at the School of ... Howard Hughes Medical Institute, and colleagues recently published ...
(Date:4/17/2014)... MD, was recently invited to submit a review ... Microbiology , one of the world,s foremost scientific ... specialist, and chair of the Department of Pediatrics ... analyzed the epidemiology and microbiology of co-infections during ... as more recent 2009 novel H1N1 pandemic. ...
(Date:4/17/2014)... Rochelle, NY, April 17, 2014U.S. military personnel who ... plus impact" concussive traumatic brain injury (TBI) were ... evacuated for other medical reasons. Differences in measures ... depression 6-12 months after injury are reported in ... a peer-reviewed journal from Mary Ann Liebert, Inc., ...
(Date:4/17/2014)... as many as 10 million older Americans suffer from ... isolation. , However, new research a project that ... for six years found that Internet use among ... more than 30 percent. , "That,s a very strong ... of telecommunication, information studies and media who led the ...
(Date:4/17/2014)... affects about one in five infants in the United ... the first several months after birth. Research into probiotic ... however, the April 1, 2014 issue of the ... a study, "Probiotics and Infant Colic," concluding that the ... infant colic did not reduce crying or fussing ...
Breaking Medicine News(10 mins):Health News:CU researchers discover target for treating dengue fever 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:Internet use can help ward off depression among elderly 2Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2
... ... help physicians find government physician jobs as they were recently awarded a General Services ... of locum tenens or temporary physician job opportunities to their providers. , ... Denver, CO (PRWEB) April ...
... ... as: $100 gift certificate to the Aviator Sports and Event Center, free parking, an ... on Aviators’ merchandise, plus many more exciting perks! , ... (PRWEB) April 16, 2010 -- ...
... ... provide the user with ingredients like creatine which are intended to enhance performance in ... formulations behind references of proprietary formulations, often relying upon excessive dosages of caffeine to ... ...
... April 16, 2010 Biogen Idec (NASDAQ: BIIB) ... from a one-year, longitudinal health outcomes study (n=324) in ... infusions of TYSABRI (natalizumab) reported improvements in quality of ... overall improved cognitive function, as measured by validated tools. ...
... ... ... recognizes the week of April 18 – 24 as National Medical Laboratory Professionals’ Week. ... be held on April 21, from 1:00 p.m. to 3:00 p.m. at its 1 Diamond ...
... , (WASHINGTON, April 15, 2010) The socioeconomic ... potentially significant factor in the availability of high-quality health-care ... A new study from the Acute Leukemia Working Party of ... that in Europe, socioeconomic factors have a direct correlation ...
Cached Medicine News:Health News:Onyx M.D. Awarded GSA Schedule Contract Creating Increases Access to Government Physician Jobs 2Health News:Onyx M.D. Awarded GSA Schedule Contract Creating Increases Access to Government Physician Jobs 3Health News:NY A's Pro Hockey Team Announces Ticket Pricing & Benefits 2Health News:Creatine Pioneers Launch New Pre-workout Supplement 2Health News:Patient-reported outcomes study shows improvements in quality of life among patients after 1 year of treatment with TYSABRI 2Health News:Patient-reported outcomes study shows improvements in quality of life among patients after 1 year of treatment with TYSABRI 3Health News:Summit Medical Group Celebrates National Laboratory Professionals' Week 2Health News:Human development index linked to stem cell transplant rates and success in leukemia patients 2Health News:Human development index linked to stem cell transplant rates and success in leukemia patients 3
(Date:1/14/2014)... Animal Emergency Critical Care, a LifeCentre partner practice, located at 165 ... the first in Loudoun County to receive ... Susan M. Barnes , Medical Director, is a well-seasoned veterinarian of ... Taylor , are avid scuba divers. "As altitude skiers and hikers, ...
(Date:1/14/2014)... , Jan. 14, 2014 NineSigma , ... hold its Innovation Leadership Summit , May 14-16, ... Cleveland Ohio . ... and organizations committed to breakthrough achievements through open innovation. ...
(Date:1/14/2014)... , January 14, 2014 Equashield ... for hazardous drugs, today announced that it has ... straight year.   Equashield,s closed systems ... pharmacists, nurses and other medical professionals who prepare ...
Breaking Medicine Technology:Hyperbaric Veterinary Medicine (hvm) Announces Animal Emergency Critical Care Installs A Small Animal Hyperbaric Chamber 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 4Equashield's Sales Grow by 60% in 2013 2
... (Nasdaq: ATHX ), a clinical stage ... Retail Investor Conferences.com presentation is available for on-demand ... Executive Officer of Athersys, presented to retail investors ... To view the archived presentation, click on ...
... Corporation, a privately held, clinical stage biopharmaceutical company developing ... today announced the appointment of Dr. Dennis Fenton, long-time ... Fenton,s appointment expands the Genelux Corporation board to 5 ... build one of the world,s most successful pharmaceutical companies ...
Cached Medicine Technology:Athersys, Inc. - Retail Investor Conferences.com Presentation Now Available Online 2Genelux Corporation Expands Board of Directors, Appointing Dennis Fenton, Former Amgen Executive 2
... Bulb Direct has been selling ... since 1996, and we are ... satisfaction guarantee. Check out our ... see our discount light bulbs ...
... Bulb Direct has been selling ... since 1996, and we are ... satisfaction guarantee. Check out our ... see our discount light bulbs ...
... been selling replacement bulbs on ... we are extremely proud of ... out our catalog of replacement ... light bulbs specials. ,Check ...
... Symphony family of Pacemakers, Ela presents the ... lighter than a passport, will take your ... technologies, and delivering powerful monitoring. ELA ... dual-chamber and atrial tracking modes in patients ...
Medicine Products: